markets.financialcontent.com ·
stockstory 2026 5 10 health catalyst hcat reports q1 everything you need to know ahead of earnings
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedHealth Catalyst, a healthcare data analytics company, faces declining revenue but stock has rallied. The commercial mechanism is weak: no specific product/commodity price impact, no scarcity, no margin squeeze identified. The event is single-company-specific with no broader supply chain or sector-wide implications beyond the healthcare IT subsector.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Health Catalyst to report Q1 earnings after market hours on Monday.
- Previous quarter revenue: $74.68 million, down 6.2% YoY.
- Analysts expect 12.9% YoY revenue decline for Q1.
- Stock up 49.6% over the past month despite expected decline.
- Average analyst price target: $1.79 vs current $1.52.
Health Catalyst's Q1 earnings are expected to show a 12.9% YoY revenue decline, likely causing a 2-4% stock drop in 48h.
Sign in to see all sector verdicts, full thesis and counter-argument debate.